A study of long-term effect of dupilumab on skin barrier function in pediatric participants with atopic dermatitis

Trial Identifier: LPS17764
Sponsor: Sanofi
Collaborator:
Regeneron Pharmaceuticals
Start Date: February 2024
Primary Completion Date: April 2027
Study Completion Date: May 2027
Condition: Eczema

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
UNITED KINGDOM, Sheffield SHEFFIELD, Sheffield, UNITED KINGDOM, S10 2TH
UNITED STATES, Colorado DENVER, Colorado, UNITED STATES, 80206
UNITED STATES, Missouri ST. LOUIS, Missouri, UNITED STATES, 63104
UNITED STATES, New York NEW YORK, New York, UNITED STATES, 10016